Aminoalkoxybenzyl pyrrolidines as novel human urotensin-II receptor antagonists
摘要:
High throughput screening of the corporate compound collection led to the discovery of a novel series of substituted aminoalkoxybenzyl pyrrolidines as human urotensin-II receptor antagonists. The synthesis, initial structure-activity relationships, and optimization of the initial hit that led to the identification of a truncated sub-series, represented by SB-436811 (1a), are described. (c) 2005 Elsevier Ltd. All rights reserved.
Urotensin-II receptor antagonists: Synthesis and SAR of N-cyclic azaalkyl benzamides
作者:Jian Jin、Ming An、Anthony Sapienza、Nambi Aiyar、Diane Naselsky、Henry M. Sarau、James J. Foley、Kevin L. Salyers、Steven D. Knight、Richard M. Keenan、Ralph A. Rivero、Dashyant Dhanak、Stephen A. Douglas
DOI:10.1016/j.bmcl.2008.06.019
日期:2008.7
SAR exploration of the central diamine, benzyl, and terminal aminoalkoxy regions of the N-cyclic azaalkyl benzamide series led to the identification of very potent human urotensin-II receptorantagonists such as 1a with a K(i) of 4 nM. The synthesis and structure-activity relationships (SAR) of N-cyclic azaalkyl benzamides are described.
[EN] UROTENSIN-II RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DE RECEPTEUR D'UROTENSINE II
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2001045711A1
公开(公告)日:2001-06-28
The present invention relates to pyrrolyl and pyridyl derivatives, pharmaceutical compositions containing them and their use as inhibitors of urotensin II.